3-methoxy-o-demethylencainide has been researched along with Tachyarrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Echt, DS; Lee, JT; Roden, DM; Woosley, RL | 1 |
| Davy, JM; Dorian, P; Fain, ES; Kates, RE; Winkle, RA | 1 |
2 other study(ies) available for 3-methoxy-o-demethylencainide and Tachyarrhythmia
| Article | Year |
|---|---|
Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Encainide; Female; Heart Conduction System; Humans; Male; Middle Aged; Tachycardia; Ventricular Fibrillation | 1989 |
Effects of encainide and its metabolites on energy requirements for defibrillation.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Dogs; Electric Countershock; Electrocardiography; Electrodes, Implanted; Encainide; Female; Male; Tachycardia; Time Factors | 1986 |